Pioneer Group

ImmuONE is a biotech company specializing in providing in vitro cell culture services for safety assessment, with a focus on respiratory health. The company offers solutions for inhalation toxicology, irritation sensitization, alveolar clearance, and inflammation. ImmuONE's expertise includes human alveolar macrophage responses and epithelial cell culture platforms, as well as testing services that utilize respiratory tissue models closely resembling lung physiology. These models enable healthcare providers to develop innovative in vitro products and testing services for inhalation safety assessment using advanced techniques.

Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services.

ImmuONE is a biotech company specializing in providing in vitro cell culture services for safety assessment, with a focus on respiratory health. The company offers solutions for inhalation toxicology, irritation sensitization, alveolar clearance, and inflammation. ImmuONE's expertise includes human alveolar macrophage responses and epithelial cell culture platforms, as well as testing services that utilize respiratory tissue models closely resembling lung physiology. These models enable healthcare providers to develop innovative in vitro products and testing services for inhalation safety assessment using advanced techniques.

Bastion Therapeutics is a preclinical stage biotechnology company focused on developing innovative anti-inflammatory cell therapies. Utilizing its proprietary platform technology, the company aims to enhance regulatory T cells (Tregs) within the immune system. By targeting neuroinflammation in critical areas of the central nervous system, Bastion Therapeutics seeks to protect neurons and improve synaptic connectivity, ultimately helping patients to maintain cognitive function and prevent deterioration. Through its research and development efforts, the company is positioning itself to address significant unmet medical needs in the realm of neuroinflammatory conditions.

NunaBio is a privately-owned specialist DNA development company based in England, United Kingdom. The company focuses on chemical and biological technologies, providing a diverse array of products and services, including long and short deoxyribonucleic acid products available in various scales, from microgram to gram. NunaBio is involved in contract research and development, as well as manufacturing, offering capabilities in cell therapies, vaccines, diagnostics, gene therapies, and advanced DNA biosensing. By delivering these innovative solutions, NunaBio aims to support healthcare professionals in their efforts to treat patients effectively.

Transdermal Diagnostics is a technology company focused on enhancing the prevention, diagnosis, and management of chronic conditions, particularly diabetes. It has developed a wearable technology platform that facilitates needle-free and continuous monitoring of glucose levels. This innovative approach utilizes affordable, disposable patches, allowing individuals with diabetes and prediabetes to gain valuable biological insights. By providing real-time data, Transdermal Diagnostics empowers users to make informed decisions about their health, ultimately promoting a healthier lifestyle.